Skip to main content

Table 4 Between-group comparisons on primary and secondary outcomes at 24-month follow-up (ANCOVA)

From: Feasibility and long-term efficacy of a proactive health program in the treatment of chronic back pain: a randomized controlled trial

 

IG (N = 189) M+ (95% CI)

CG (N = 255) M+ (95% CI)

Between group

p

Cohen’s d* [95% CI]

Primary outcomes

 Back pain severity (CPGQ)

characteristic pain intensity (0–100)

38.7 (36.2–41.2)

41.5 (39.3–43.6)

0.110

−0.16 [− 0.34 to 0.03]

disability points (0–6)

1.6 (1.4–1.8)

2.0 (1.8–2.2)

0.025

−0.24 [− 0.43 to − 0.05]

 Health-related quality of life (SF-12)

physical component (0–100)

43.3 (42.0–44.5)

41.0 (39.9–42.0)

0.007

0.26 [0.07 to 0.45]

mental component (0–100)

46.9 (45.5–48.3)

46.7 (45.5–48.0)

0.855

0.02 [−0.21 to 0.17]

Secondary outcomes

 Psychological distress (PHQ-4)

sum score (0–12)

2.7 (2.4–3.1)

3.2 (2.9–3.4)

0.040

−0.24 [− 0.42 to − 0.05]

 Risk of chronifi-cation (STarT-G)

total score (0–9)

2.6 (2.3–2.8)

3.0 (2.8–3.3)

0.009

− 0.25 [− 0.44 to − 0.07]

 Physical activitya

days per week with at least 10 min physical activity (0–7)

2.7 (2.5–2.9)

2.4 (2.2–2.6)

0.028

0.21 [0.03 to 0.40]

  1. IG intervention group, CG Control group, p significance value; M+: values of the group means adjusted for baseline-score, StarT-G total risk score and satisfaction with medical care of back pain at baseline, CI Confidence interval; CPGQ Chronic Pain Grade Questionnaire; SF-12: Short Form 12; PHQ-4: Patient Health Questionnaire 4; STarT-G: Keele STarT back Screening Tool, German Version
  2. aphysically active in a way that one starts to sweat or gets out of breath
  3. Cohen’s d*: if higher scores of the outcome parameter describe worse health condition (e.g. GCPS-parameters), minus d means IG is superior to CG and plus d means IG is worse than CG; if higher scores describe better health conditions (e.g. SF-12 parameters), minus d signifies IG is inferior to CG and plus d means IG is better than CG